Orthofix names new board members; Biotronik wins CE mark for PK Papyrus stent;

@FierceMedDev: Supreme Court to decide on Medtronic, Boston Scientific patent fight by June. Story | Follow @FierceMedDev

@MarkHFierce: Check out our latest issue of FierceDiagnostics--lots of good stuff and just sent out. Newsletter | Follow @MarkHFierce

> Orthofix International ($OFIX) named two new independent board members as its longtime chairman retires. Item

> Bacterin International ($BONE) said it has obtained a U.S. patent for a method to produce a demineralized bone matrix and is pursuing similar legal protection in other countries. Item

> MedCity News outlines 5 ways mobile technology is revolutionizing medical device sales. Item

> ReVerse Medical won both FDA and CE-mark approvals for its ReVerse family of products designed for intracranial neurovascular use. Story

> Germany's Biotronik gained a CE mark to use its PK Papyrus stent for emergency treatment of acute coronary artery perforations. Story

Biotech News

@FierceBiotech: Morningstar analyst ranks the top 11 pharma giants' prospects, putting GSK on top. More | Follow @FierceBiotech

@JohnCFierce: ICYMI: Novartis to chop 371 jobs, shutter research center in global R&D shakeup. Story | Follow @JohnCFierce

@DamianFierce: Medtronic looks to widen its renal denervation lead with latest trial. Article | Follow @DamianFierce

@EmilyMFierce: This is worth a listen: Teaching Science Through Hip Hop. More | Follow @EmilyMFierce

> GlaxoSmithKline picks discovery-stage winners in R&D Star Search. More

> FDA puts a clamp on Curis cancer drug program after patient dies of liver failure. Story

> Karyopharm joins biotech's fall IPO parade with $109M haul. Article

Pharma News

@FiercePharma: Trending now: Novartis eyes animal health sale as first slim-down move: Bloomberg. Story | Follow @FiercePharma

@CarlyHFierce: ICYMI: Here's yesterday afternoon's Vivus Q3 earnings call transcript. More | Follow @CarlyHFierce

> U.K. caps drug spending, forcing pharma to curtail prices. More

> Novartis plots sales cuts in U.K. amid R&D restructuring. Story

> Will Merck be next to join Big Pharma's asset-sale parade? Article

Drug Delivery News

@MichaelGFierce: Gold nanoparticles first to deliver RNA to brain tumors. More | Follow @MichaelGFierce

> Langer lab makes synthetic 'good cholesterol' for cardiovascular drug delivery. Item

> IBM uses hydrogel to prolong delivery of Roche's Herceptin. More

> Gold nanoparticles first to deliver RNA to brain tumors. Story

> Platinum drug delivery method snuffs cancer's power source. Article

> Novo Nordisk wins FDA approval for two automated-dose insulin pens. News

> Study: Arrowhead's hep B RNAi drug could offer 'functional cure'. Report

Diagnostics News

> Cancer Dx test maker Veracyte launches successful IPO. Item

> Ariosa defeats Sequenom in prenatal testing patent battle. More

> Illumina, Natera, Ariosa tests gain contracts with CA's prenatal Dx program. Story

> AutoGenomics pulls IPO plans and mulls possible private offering instead. Article

> PerkinElmer to sell Transgenomic molecular Dx oncology tests overseas. Report

> Alere's new HIV test could gain momentum from Affordable Care Act. News

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.